Indeed, an exosome investigation revealed that the synaptic protein levels decreased years before clinical symptoms manifested and inversely correlated with cognition in AD and frontotemporal dementia patients, whereas Amyloid Beta (Aβ)1–42 or phospho-Thr181-Tau did not (Goetzl et al., 2016). The gene discussed is MAPT; the disease is Alzheimer disease.